Researchers have made a broad-spectrum antiviral that works against several virus families by blocking N-glycans—long thought of as undruggable targets (Sci. Adv. 2025, DOI: 10.1126/sciadv.ady3554).

Syzygium, a genus within the Myrtaceae family, harbours a diverse array of secondary metabolites that underpin its traditional and emerging antidiabetic uses. Across species such as Syzygium cumini ...